Pharmacokinetics and Pharmacodynamics of Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD
Diabetes Obes Metab 2023 Nov 30;[EPub Ahead of Print], T Eissing, SC Goulooze, P van den Berg, M van Noort, M Ruppert, N Snelder, D Garmann, J Lippert, R Heinig, M Brinker, HJL HeerspinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.